ArticleArthritis research & therapy2015

Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.

Annemarie E M van Nieuwenhuijze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.